Halal Nutraceuticals and Vaccines Market
Halal Nutraceuticals & Vaccines Market: Middle East & Africa Market Estimated to Record the Highest CAGR During the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016–2026
- 2017-01-13
- REP-GB-2703
- 180 pages
-
An Incisive, In-depth Analysis on the Halal Nutraceuticals And Vaccines Market
This study offers a comprehensive, 360 degree analysis on the Halal Nutraceuticals And Vaccines market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Halal Nutraceuticals And Vaccines market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
COVID -19 : Impact Analysis
Request the coronavirus imapact analysis across industries and markets
Request Covid -19 ImpactThe volatile halal neutraceuticals and vaccines market in Japan is expected to impact future volume and value of the market
The global halal neutraceuticals and vaccines market is expected to expand manifold during the period of forecast. The market is anticipated to reach a value of more than US$ 80 Mn by the end of 2026. The global halal neutraceuticals and vaccines market is predicted to record a promising CAGR of 7.7% over the assessment period. A growing Muslim population, rising demand for halal products, and increased government initiatives to promote halal products are likely to expedite revenue growth of the global halal neutraceuticals and vaccines market. The global halal nutraceuticals and vaccines market is expected to represent incremental opportunity of more than US$ 42,000 Mn between 2016 and 2026.
Regional forecast of the global halal neutraceuticals and vaccines market
Asia Pacific excluding Japan represents the largest market in terms of value share for halal nutraceuticals and vaccines across the globe and is expected to remain dominant in terms of value share over the forecast period. Rising demand for consumption of halal certified dietary supplements such as calcium, fish oil, protein powder and others are supporting the growth of the market across the region. The Western Europe market is expected to show significant growth in the next decade and hold a market value in excess of US$ 4,000 Mn by 2026, registering a CAGR of 6.5% over the forecast period. On the other hand, the markets of North America, Latin America, Japan and Eastern Europe will be stagnant and will exhibit slow growth till the end of 2026. Asia Pacific excluding Japan is the most attractive market with a market attractiveness index of more than 4.2 during the forecast period. Middle East and Africa is expected to be the second most lucrative market in the global halal nutraceuticals and vaccines market, recording the highest CAGR of 8.5% within the foreseen period. Japan is expected to be the least attractive market for halal nutraceuticals and vaccines.
Comprehensive study of Japan’s halal neutraceuticals and vaccines market
Japan is anticipated to be the smallest market for halal products, growing at a CAGR of 4.7%. In Japan, halal vaccines are expected to be launched in the year 2022 and the market is forecasted to cross US$ 0.1 Mn by 2022 end and is expected to be valued more than US$ 0.3 Mn by 2026 end. Halal dietary supplements product type segment is estimated to be valued above US$ 110 Mn by 2026 end, expanding at a CAGR of 4.5% during the forecast period. Hospital pharmacies is the largest distribution channel segment in terms of revenue share in Japan and is expected to account for more than US$ 45 Mn by 2026. Supermarkets segment is anticipated to hold 10.71% market share by 2026. Retail pharmacies segment is expected to grow at the lowest CAGR of 3.8% owing to the more preferred conventional distribution methods such as hospital pharmacies. General wellbeing was the largest application segment in 2016 in Japan, accounting for more than US$ 15 Mn in market value and is expected to account for less than US$ 39 Mn by 2026 end. Immune & Digestive Health was the second largest segment, accounting for 20.7% of the halal nutraceuticals and vaccines market in the region in 2026 and is expected to account for more than US$ 20 Mn by 2026. Weight loss segment is estimated to grow at the lowest CAGR of 2.8% over the forecast years.
Future Market Insights presents a detailed study of the global halal neutraceuticals and vaccines market in a brand new publication titled “Halal Nutraceuticals & Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In this report, we have forecasted the changing climate of the global halal neutraceuticals and vaccines market. We have scanned all the major geographies, analysed the potential of all the market segments and critically assessed all the opportunities available for companies operating in the global halal nutraceuticals and vaccines market. In this 10-year forecast, we have primarily highlighted the major developments that are expected to affect the fabric of the global halal nutraceuticals and vaccines market. To create a stand-alone market insight our team of analysts has delved deep into the market and identified the key drivers, restraints and trends that are anticipated to shape the performance of the global halal nutraceuticals and vaccines market. Drivers and restraints not only define the market size and value but also impact the business operations of key players. Through extensive research, our analysts have studied how the different market elements are predicted to affect the future and the present development of the global halal neutraceuticals and vaccines market. Through this report, we have tried to provide useful insights to leading market players to plan their differentiating strategies capable of evolving with the changing market landscape.
Report description
The report on the global halal neutraceuticals and vaccines market starts with an executive summary followed by the market overview and key definitions. Executive summary of the report gives a 360 degree view of the revenue estimation of the global halal neutraceuticals and vaccines market. We also present the market taxonomy in this section where we have segmented the global halal neutraceuticals and vaccines market on the basis of product type, distribution channel, application, and region. In the market dynamics section, we have highlighted the factors, restraints, opportunities and trends likely to define market growth in the forthcoming years.
We have reserved the last section of the report for key shareholders of the global halal neutraceuticals and vaccines market. In this section, we have focussed on some of the leading companies operating in the global halal neutraceuticals and vaccines market and evaluated their business performance and long-term and short-term goals. This section is intended to provide report audiences with a dashboard view of the competitive landscape of the global halal neutraceuticals and vaccines market.
Global halal neutraceuticals and vaccines market: Segmentation
|
Products |
Distribution Channel |
Applications |
Regions |
|---|---|---|---|
|
|
|
|
Research methodology
In this report, we divulge some extremely relevant data pertaining to the global halal neutraceuticals and vaccines market. Our analysts have conducted in-depth secondary research to determine the overall market size, top industry players, top products and top applications, top distributors and manufacturers. Our core team of analysts has spoken elaborately with key global market players to fetch relevant data. We have then sliced and diced this pile of data gathered through secondary and primary research and validated the same using the triangulation method. Finally, we have scrutinised this data using advanced tools to obtain qualitative and quantitative insights about the industry.
Key metrics
In this report on the global halal neutraceuticals and vaccines market, we have encapsulated the key metrics that accurately describe the global halal neutraceuticals and vaccines market and used this data to compare market performance across the various segments and regions. We understand that the nature of the global economy is very volatile and hence besides estimating the Compound Annual Growth Rate (CAGR) for the global and regional markets, we have also analysed the global halal neutraceuticals and vaccines market on the basis of growth parameters such as Year-on-Year (Y-o-Y) growth to understand market predictability and to identify the right opportunities likely to emerge in the global halal neutraceuticals and vaccines market. Further, we have studied the different market segments by conducting a Basis Point Share (BPS) analysis to understand the relative contribution of individual segments to overall market growth. We feel this detailed level of information is important to identify the many key trends governing the global halal neutraceuticals and vaccines market.
Another notable feature of our report is an analysis of the global halal neutraceuticals and vaccines market revenue in terms of absolute dollar opportunity. While this is usually overlooked when forecasting the market, we believe absolute dollar opportunity analysis is critical in assessing the level of opportunity that market providers can look to achieve and also to identify potential resources in the global halal neutraceuticals and vaccines market. Finally, we know the importance of dissecting the different market segments in terms of their growth and performance in the global halal neutraceuticals and vaccines market, and towards this end, we have developed a market attractiveness index to help market players identify current and future market opportunities.
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.